BSE filing, NSE: RAJSREESUG. Summary written from the filing by ALFA Finder's alert engine.
Rajshree Sugars & Chemicals Ltd: key numbers
- Share price
- ₹27.26
- Market cap
- ₹90.33 Cr
- Revenue (annual)
- ₹544.7 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- -11.2×Sector 28.6×
- Promoter holding
- 40.72%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rajshree Sugars & Chemicals Ltd
All →Rajshree Sugars & Chemicals Board Meeting Date
RAJSHREE SUGARS & CHEMICALS LIMITED intimated a board meeting on 13 Nov 2026 to consider unaudited standalone half-yearly results for September 2026. Trading window remains closed until 15 Nov 2026.
Rajshree Sugars & Chemicals Legal & Regulatory
Rajshree Sugars discloses a favorable order dropping ₹62.84 Cr Central Excise proceedings on molasses. The Commissioner ruled in the company's favor with nil financial impact.
- Value
- ₹62.84 Cr
Rajshree Sugars & Chemicals Legal & Regulatory
Rajshree Sugars received a BSE cautionary letter for a late disclosure of a January 2025 Tamil Nadu order. No monetary penalty was imposed; operations are unaffected.
Rajshree Sugars & Chemicals Other Announcement
Rajshree Sugars & Chemicals Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The disclosure outlines the company's current shareholder distribution.
Rajshree Sugars & Chemicals Other Announcement
Rajshree Sugars & Chemicals submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, as received from its registrar.
Rajshree Sugars & Chemicals Business Update
Rajshree Sugars has released its operational data for September 2026, detailing production and sales volumes for its sugar and molasses units across three factory locations.
Other business update announcements
All →Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.
Fino Payments Bank Business Update
Fino Payments Bank's October 2026 update showed deposits crossing Rs 3,000 Crore for the first time. Loan referral disbursals rose 316% year-on-year to Rs 301 Crore.
Ugar Sugar Works Business Update
Ugar Sugar Works has informed the exchanges that crushing for the 2026-27 season started at its Ugar Unit on 06 Nov 2026. Crushing will ramp up to full capacity over time.
Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
GSM Foils Business Update
GSM Foils Limited reported Net Sales of Rs. 14,63,47,636 for October 2026, with April-October cumulative sales of Rs. 1,59,69,98,607. The monthly sales update is filed under Regulation 30.
- Value
- ₹14.63 Cr
Runwal Enterprises Business Update
Runwal Enterprises adopted a fair disclosure code for unpublished price sensitive information under SEBI PIT Regulation 8. The code is hosted on the company website.